ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

NCI Says Breast Cancer Rate In Marin Matches Other West Coast Counties

April 18, 2003

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000